Provided by Tiger Trade Technology Pte. Ltd.

MannKind

3.94
-0.2200-5.29%
Post-market: 3.950.0100+0.25%19:30 EDT
Volume:5.19M
Turnover:20.94M
Market Cap:1.27B
PE:-28.14
High:4.36
Open:4.16
Low:3.92
Close:4.16
52wk High:6.51
52wk Low:2.23
Shares:321.54M
Float Shares:309.97M
Volume Ratio:1.74
T/O Rate:1.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1400
EPS(LYR):0.0200
ROE:32.74%
ROA:0.79%
PB:-18.85
PE(LYR):197.00

Loading ...

MannKind Partners with Rose Pharma on Inhaled Rapid-Acting GLP-1 Weight-Loss Therapy

Reuters
·
Yesterday

MannKind and Rose Pharma Inc Enter Licensing and Collaboration Agreement to Develop an Inhaled Rapid-Acting, Short-Duration Glp-1 for Weight Management

THOMSON REUTERS
·
Yesterday

MannKind Corporation: Specific Financial Terms of Agreement were not Disclosed

THOMSON REUTERS
·
Yesterday

MannKind Corporation - Rose Pharma Receives Exclusive Worldwide License for Technosphere Technology

THOMSON REUTERS
·
Yesterday

MannKind Corporation - to Provide Development and Manufacturing Support Through Phase 1B in Weight Management Study

THOMSON REUTERS
·
Yesterday

MannKind Corporation - to Receive Equity Interest in Rose Pharma and Potential Royalties on Future Net Sales

THOMSON REUTERS
·
Yesterday

MannKind Corporation - to Have Representation on Rose Pharma Board of Directors

THOMSON REUTERS
·
Yesterday

Wells Fargo Remains a Buy on MannKind (MNKD)

TIPRANKS
·
Sep 02

MannKind to Present at Upcoming Investor Conferences

GlobeNewswire
·
Sep 02

MannKind (MNKD) Stock May Be Fairly Priced After 27% Slide

Simply Wall St.
·
Aug 27

MannKind Corporation - Selling Stockholders May Offer up to 12,853,470 Shares Including 2,412,632 Warrant Shares - SEC Filing

THOMSON REUTERS
·
Aug 22

How MannKind’s (MNKD) Rising Revenue but Renewed Losses Could Reshape Its Growth Investment Story

Simply Wall St.
·
Aug 18

MannKind Director Steven B. Binder Sells 39,051 Shares Worth $158,547

Reuters
·
Aug 11

Is MannKind (MNKD) Undervalued After Positive INFLO 1 Data For Its IPF Pipeline?

Simply Wall St.
·
Aug 11

MannKind Posts Transcript of Q2 2026 Earnings Call

Reuters
·
Aug 07

MannKind is Maintained at Overweight by Wells Fargo

Dow Jones
·
Aug 07

MannKind's Diversified Portfolio Seen Leading to Higher Revenue in H2, Wedbush Says

MT Newswires Live
·
Aug 07

Viridian Therapeutics Q2 Net Loss Widens as Lumvoa Launch Lifts Costs

Reuters
·
Aug 06

Amylyx Pharmaceuticals Q2 Posts Higher than Expected Loss

Reuters
·
Aug 06

Scholar Rock Q2 Net Loss Narrows

Reuters
·
Aug 06